Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_assertion type Assertion NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_head.
- NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_assertion description "[PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_provenance.
- NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_assertion evidence source_evidence_literature NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_provenance.
- NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_assertion SIO_000772 7749407 NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_provenance.
- NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_assertion wasDerivedFrom befree-2016 NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_provenance.
- NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_assertion wasGeneratedBy ECO_0000203 NP1320643.RAujPSd9BLWNmJZNZUJe3JnwN5NCNTROOLvT2MBFSFkzI130_provenance.